Cullinan Therapeutics Inc (CGEM)
Stock-Based Compensation
$32.84M
TTM · Period ending: · USD
CGEM Stock-Based Compensation
Latest reported$32.84Mperiod ending
Latest reported$32.84Mperiod ending
CGEM TTM Stock-Based Comp ($17.00K → $32.84M)
TTM stock-based compensation
High-resolution chart · PNG
CGEM stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 32,842,000 | |
| 34,282,000 | |
| 36,040,000 | |
| 38,362,000 | |
| 38,325,000 | |
| 38,971,000 | |
| 37,824,000 | |
| 35,709,000 | |
| 34,019,000 | |
| 31,406,000 | |
| 30,438,000 | |
| 30,432,000 | |
| 27,963,000 | |
| 28,651,000 | |
| 27,957,000 | |
| 32,589,000 | |
| 31,875,000 | |
| 27,432,000 | |
| 24,375,000 | |
| 12,230,000 | |
| 7,673,000 | |
| 3,508,000 | |
| 0 | |
| 0 | |
| 0 | |
| 8,500 | |
| 17,000 |